Sort
48,018 grants matching “immunotherapy”
Targeting exosomal PDL1 to improve immunotherapy
$444,750Wei Guo · Wistar Institute · P50 · FY2025 · CA
Molecular Diagnostics Core Laboratory
$444,657Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
Imaging Costimulation Blockade Resistant Rejection
$444,656Andrew B Adams · University Of Minnesota · U01 · FY2021 · AI
Exploiting Integrin Signaling to Overcome Resistance to Immunotherapy
$444,655David G Denardo · Washington University · R01 · FY2021 · CA
The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer
$444,653Don Lynn Gibbons · University Of Tx Md Anderson Can Ctr · R37 · FY2021 · CA
Miami Center for AIDS Research
$444,607Savita Pahwa · University Of Miami School Of Medicine · P30 · FY2024 · AI
Modeling immunity with a hybrid lymph node tissue-chip
$444,594Rebecca R Pompano · University Of Virginia · R01 · FY2019 · AI
Therapeutic targeting of multiple glioblastoma phagocytosis checkpoints using a novel bispecific antibody
$444,583Wen Jiang · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · NS
Combating Breast Cancer Brain Metastasis by Blocking the Two-Pronged Driver Kinase Function of CDK5
$444,573Dihua Yu · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Combating Breast Cancer Brain Metastasis by Blocking the Two-Pronged Driver Kinase Function of CDK5
$444,573Dihua Yu · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Spherical Nucleic Acid nano-architectures as first-in-class cGAS agonists for the immunotherapeutic treatment of Glioblastoma.
$444,533Alexander H. Stegh · Washington University · R01 · FY2024 · CA
Development and maintenance of human glycan and phospholipid antibody repertoires
$444,525John Franklin Kearney · University Of Alabama At Birmingham · U19 · FY2022 · AI
Immunization to Block the Effects of Nicotine
$444,524Paul Pentel · Hennepin Healthcare Research Institute · R01 · FY2010 · DA
Interplay Between Cancer and Immune Cells on Targeted Therapy
$444,515Peter Poon-Hang Lee · Stanford University · R01 · FY2010 · CA
Scientific Core B
$444,512Holden T. Maecker · Stanford University · U19 · FY2017 · AI
Amyloid-Beta Oligomer Selective Immunotherapy for Prodromal or Mild Alzheimer Disease
$444,503William Goure · Acumen Pharmaceuticals, Inc. · U01 · FY2017 · AG
An innate immune checkpoint in cancer immunotherapy
$444,441Carla Rothlin · Yale University · R01 · FY2019 · CA
Epigenetic Regulation of Head and Neck Cancer Immune Evasion
$444,406Chao Lu · Columbia University Health Sciences · R01 · FY2024 · DE
Roles of Coactivator-Associated Arginine Methyltransferase 1 in B cell activation and lymphomagenesis
$444,385Margarida Santos · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Roles of Coactivator-Associated Arginine Methyltransferase 1 in B cell activation and lymphomagenesis
$444,382Margarida Santos · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Immunophysiological Mechanisms in the Biological Therapy of Cancer
$444,359Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Mutational signature analysis: methods and applications to the clinic
$444,343Peter Park · Harvard Medical School · R01 · FY2023 · CA
An In Situ Patient-specific Chemo-Immunotherapy for Skin Cancers
$444,330Louis D Falo · University Of Pittsburgh At Pittsburgh · P50 · FY2014 · CA
Exploiting the immunomodulatory effects of sulindac and novel non-COX inhibitory derivatives for cancer treatment
$444,328Gang Zhou · Augusta University · R01 · FY2020 · CA
Fatty Acid Synthase:Molecular Target for Breast Cancer Therapy & Chemoprevention
$444,316Ruth Lupu · Mayo Clinic Rochester · R01 · FY2009 · CA